Evidence map›Paper›PMID 34589567›Full record

ArticleData in brief2021

Data vignettes for the application of response surface models in drug combination analysis.

Nathaniel R Twarog, Nancy E Martinez, Jessica Gartrell, Jia Xie, Christopher L Tinkle, Anang A Shelat

Abstract read
In one paragraph

Article in Data in brief, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nathaniel R TwarogDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, United States.
Nancy E MartinezDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, United States.
Jessica GartrellDepartment of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, TN, United States.
Jia XieDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, United States.
Christopher L TinkleDepartment of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, TN, United States.
Anang A ShelatDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This data set contains the data used in Twarog et al. (2021) to examine the robustness and utility of response surface models in drug combination analysis. It includes simulated experimental data for the evaluation of traditional index methods, as well as a processed library of interaction metrics evaluated on the Merck OncoPolyPharmacology Screen (O'Neil et al., 2016), the scripts used to implement those metrics on all tested combinations in that screen, and scripts to evaluate the performance of those metrics in comparison with real-world mechanistic classifications. Finally, the data set includes data from several published and unpublished drug combination experiments, and scripts which allow the analyses of those experiments to be replicated and applied to new data.

Indexed as

Combination therapyResponse surface modelsSynergy

Identifiers

PMID34589567
PMCPMC8461350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.